Center for Vaccines and Immunology
Research Professional IV, Tompkins Lab
Biography
Scott K. Johnson received his B.Sc. at the University of Georgia in Animal Science in 1984 followed by his Masters at Utah State University in 1987. His experience includes 7 years continued graduate research at the University of Georgia examining endocrine and biomolecular function in reproductive physiology. This was followed by experience in private industry where he worked as a researcher and manager at Merial, Ltd. designing analytical methods for evaluation of vaccines. Most recently he has served as a research professional at the Animal Health Research Center in the college of Veterinary Science at the University of Georgia where he has focused on influenza studies including both in-vitro and in-vivo work at BSL-2 as well BSL-3 levels. He is currently working as a Research Professional with Dr. Ted Ross at the Center for Vaccine and Immunology at the University of Georgia.
Research Interests
- Vaccine Development against influenza and other viruses
- Development of animal model research in influenza and related in-vitro assays
Educational Background
MS (1987), Animal Science, Utah State University
B.Sc (1984), Animal Science, University of Georgia
Selected Publications
- Perwitasari O, Johnson S, Yan X, Register E, Crabtree J, Gabbard J, Howerth E, Shacham S, Carlson R, Tamir S, Tripp RA. Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection. PLoS One. 2016 Nov 28;11(11):e0167221.
- Jara AL, Hanson JM, Gabbard JD, Johnson SK, Register ET, He B, Tompkins SM. Comparison of Microchip Transponder and Noncontact Infrared Thermometry with Rectal Thermometry in Domestic Swine (Sus scrofa domestica). J Am Assoc Lab Anim
Sci. 2016;55(5):588-93. - Perwitasari O, Yan X, O’Donnell J, Johnson S, Tripp RA. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication. Assay Drug Dev Technol. 2015 Dec;13(10):638-49.
- Gabbard JD, Dlugolenski D, Van Riel D, Marshall N, Galloway SE, Howerth EW, Campbell PJ, Jones C, Johnson S, Byrd-Leotis L, Steinhauer DA, Kuiken T, Tompkins SM, Tripp R, Lowen AC, Steel J. Novel H7N9 influenza virus shows low infectious
dose, high growth rate, and efficient contact transmission in the guinea pig model. J Virol. 2014 Feb;88(3):1502-12. - McCutcheon KM, Gray J, Chen NY, Liu K, Park M, Ellsworth S, Tripp RA, Tompkins SM, Johnson SK, Samet S, Pereira L, Kauvar LM. Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets. MAbs. 2014 Mar-Apr;6(2):460-73.
- Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y, Baloglu E, McCauley D, Tamir S, Tompkins SM, Tripp RA. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J Virol. 2014 Sep 1;88(17):10228-43.
- Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y, Baloglu E, McCauley D, Tamir S, Tompkins SM, Tripp RA. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J Virol. 2014 Sep 1;88(17):10228-43.
- Perwitasari O, Torrecilhas AC, Yan X, Johnson S, White C, Tompkins SM, Tripp RA. Targeting cell division cycle 25 homolog B to regulate influenza virus replication. J Virol. 2013 Dec;87(24):13775-84.
- Perwitasari O, Yan X, Johnson S, White C, Brooks P, Tompkins SM, Tripp RA. Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy. Antimicrob Agents Chemother. 2013 Jan;57(1):475-83.
- Smith JH, Brooks P, Johnson S, Tompkins SM, Custer KM, Haas DL, Mair R, Papania M, Tripp RA. Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice. Vaccine. 2011 Mar 21;29(14):2568-75.
- oolums AR, Siger L, Johnson S, Gallo G, Conlon J. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production. Vaccine. 2003 Mar 7;21(11-12):1158-64.
